Early ID study

Purpose

To find out if early notification and involvement by Infectious Disease of positive blood cultures will have an impact on improving patient outcome.

Collection Instructions in TMP file

The lab will send a list of all patients with positive cultures to Con (GF216). For all patients on this list who are on the study wards (A4 and D4) or the control group wards (H4), enter:

• "1 Sample Drawn": date and time sample was drawn
• "2 Positive Culture": date and time of positive culture
• "3 Orig Antibiotic": date and time of original antibiotic prescription
  • enter name of antibiotic into the comment field
  • if patient was not on an antibiotic before, then CHECK BOX "NO orig antibiotics"
• "4 ID Consult": date and time Infectious Disease Department consult response
  • if no response or patient leaves, deceased or AMA then check box "no response"
• "5 Order": date and time order written to change to appropriate antibiotic, if change is needed
  • enter name of antibiotic into the comment field
  • if no change or patient leaves, deceased or AMA then check box "not avail."
• "6 NEW Antibiotic": date and time new antibiotic is given
  • enter name of antibiotic into the comment field
  • if NO new antibiotic is given or patient leaves, deceased or AMA then CHECK BOX "no new AB"

• Prior to sending data on a completed patient file, please write "Early ID Study" in the notes section for easy identification for Pagasa and Julie.--CMarks 12:42, 18 February 2011 (CST)

Special Cases

Suggested to Con to use similar to QA Septic Ttenbergen 13:34, 24 December 2010 (CST)

• • Only for this study, when a patient has a central line infection please include "septicemia" as a diagnosis also. This way we can capture the positive blood culture as per a previous discussion with Dr. Embil.--CMarks 14:02, 18 March 2011 (CDT)

Study Run Times

• Approved by Dr Roberts: January 2010
• Start date "January 31, 2011" --CMarks
• Review Date: 30 days after start date. Week of March 7.11.--CMarks 15:10, 21 January 2011 (CST)
• Preliminary End Date: 1 month to 3 months after start date
  • Review done March 14,2011. Plan-continue study for approximately 6 weeks and review.--CMarks 13:24, 16 March 2011 (CDT)

• what is the status of this project?--TOstryzniuk 17:18, 14 June 2011 (CDT)

Project team

• Primary contact for Data Collection: Con Marks R.N.
• Project lead and main contact for project
  • Dr. John Embil Director, Infection Diseases Program
  • Terry Wuerz, resident physician

Consistency Checks

Tmp Checker will check for the following:

• dates will need to be consistent with admit/discharge; waiting to hear back what rules will be for pts who leave.Ttenbergen 13:24, 24 December 2010 (CST)
  • I am unsure what you mean Tina.--CMarks 15:06, 21 January 2011 (CST)
• If "Positive Culture" entry is present for a patient, then there will have to be either a date or a checkbox for the other entries.
• If patient discharged and blood culture result not back before this, follow the 5 day rule to see if culture is positive before sending as a completed data file.--CMarks 14:17, 20 January 2011 (CST)
  • • CLARIFICATION--If the blood culture was sent from another ward/ER/ICU but the patient is physically located on A4 or D4 and it comes back positive the patient profile qualifies for the study. If the patient is anywhere but these wards NO information needs to be collected as they do not qualify for the study.--CMarks 13:21, 16 March 2011 (CDT)

Sending to TmpV2.mdb

Data will be sent only for the completed patient data files as is normally done on Wednesdays.--CMarks 14:22, 20 January 2011 (CST)

Statistician

The following data needs to be reported back to Dr. Embil, pending review at the review date above:

• Early ID Study data from TMPV2,Initials, ward location chart number, LOS, admit date, discharge date,and complications & comorbid conditions.

• In 1 month - the above raw data to be sent to Dr. Embil (in Excel would be fine). Julie will pull needed elements from ccmdb, database and TMPV2 and sent to Dr. Embil. This would be the end of the first week of March. The information will analyzed by Dr. Embil and team.
• Dr. Embil may asks Julie later in the project if it is continued do some minor analysis.